The dendritic cell and human cancer vaccines

This publication has 41 references indexed in Scilit:

• Consequences of Cell Death
  The Journal of Experimental Medicine, 2000
• Human acute myeloblastic leukemia cells differentiatein vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias
  European Journal of Immunology, 1999
• Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models
  Gene Therapy, 1997
• Efficient Retrovirus-Mediated Gene Transfer of Dendritic Cells Generated from CD34⁺Cord Blood Cells under Serum-Free Conditions
  Human Gene Therapy, 1997
• EFFECTIVE TUMOR IMMUNOTHERAPY USING BONE MARROW (BM)-DERIVED DENDRITIC CELLS (DCS) GENETICALLY ENGINEERED TO EXPRESS INTERLEUKIN 12
  Journal of Immunotherapy, 1997
• IL-12 AND FLT3 LIGAND DIFFERENTIALLY STIMULATE LYMPHOID AND MYELOID DENDROPOIESIS IN VIVO.
  Journal of Immunotherapy, 1997
• CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULES
  Annual Review of Immunology, 1997
• Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
  The Journal of Experimental Medicine, 1996
• Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
  The Journal of Experimental Medicine, 1994
• A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
  The Journal of Experimental Medicine, 1992